http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002241304-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b9fa13c33b79ba86e25d61d5e3cee4f2 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
filingDate | 2001-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd91c9b8b60e81463fe3f12c0aedacde http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_45bcf837e1d3084441e07138deb199ee |
publicationDate | 2002-08-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2002241304-A |
titleOfInvention | Preventive or therapeutic agent for anterior eye inflammatory disease |
abstract | (57) [Summary] [Purpose] To prevent or treat post-operative inflammation diseases such as postoperative inflammation, uveal inflammation, scleral inflammation, conjunctival inflammation, eyelid inflammation, lacrimal gland inflammation and eye trauma. To provide. A calpain inhibitor, preferably of the formula (I) [Wherein, R 1 represents an alkyl group having 1 to 4 carbon atoms or an aryl group having 6 to 10 carbon atoms which may have a substituent, and R 2 and R 3 are the same or different, Each represents hydrogen or an alkyl group having 1 to 4 carbon atoms, or R 2 and R 3 may be linked to form a ring having 3 to 7 carbon atoms, and R 4 is an aryl group, a cycloalkyl group or an aromatic group; A lower alkyl group which may be substituted with a group heterocyclic residue; Or a pharmaceutically acceptable salt thereof, for the prevention or treatment of anterior ocular inflammatory disease. |
priorityDate | 2001-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 236.